A new study in The Lancet shows the HPV vaccine has reduced cervical cancer deaths in the UK for women under 30 to effectively zero. Routine vaccinations began in 2008, and researchers found no deaths in the 20-24 age group between 2020-2024, compared to 23 expected without the vaccine.
New research shows HPV vaccination for 12-13 year olds has nearly eliminated cervical cancer deaths before age 30, saving around 200 lives in England. Vaccination rates are below WHO targets, prompting calls for urgent action.
Landmark research shows young women vaccinated against HPV at age 12-13 have near-zero risk of cervical cancer death before 30. Over 200 lives saved in England since 2008, with no deaths recorded in 20-24 age group recently. Experts urge high vaccination rates to meet elimination goals.
Analysis in The Lancet reveals the HPV vaccine has saved approximately 200 lives in England by drastically reducing cervical cancer deaths. No deaths were recorded in women aged 20-24 between 2020-2024, a period where 23 would have been expected without vaccination.
A study found HPV vaccination virtually eliminates cervical cancer deaths before age 30. However, falling vaccination rates in England could lead to hundreds of avoidable deaths annually, reversing progress towards elimination.
Vietnam's Ministry of Health will include the HPV vaccine in its expanded immunization program starting July 1, 2026, aiming to vaccinate 18,000 girls annually against HPV-related diseases, including cervical cancer. This move aims to increase vaccine accessibility, especially for economically disadvantaged groups.
Gyeonggi Province gubernatorial candidate Yang Hyang-ja pledged to expand free HPV vaccination support to young men, alongside other welfare policies like AI/OTT support and enhanced public healthcare. She stated that true welfare lies in building robust systems, not just cash handouts, with funding from excess tax revenue from advanced industries.
